Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James D Berry

Showing results (31-40 of 176) with videos related to

Pageof 18
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 5, 2026
Bridging the gap: understanding participation barriers in ALS clinical trials through on-the-ground insightsErica Scirocco, Allison Pogemiller Bulat, Judith R Carey, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 19, 2012
Dexpramipexole effects on functional decline and survival in subjects with amyotrophic lateral sclerosis in a Phase II study: subgroup analysis of demographic and clinical characteristicsStacy A Rudnicki, James D Berry, Evan Ingersoll, et al.
Journal of Neuroengineering and Rehabilitation|December 20, 2024
Free-living monitoring of ALS progression in upper limbs using wearable accelerometersMarcin Straczkiewicz, Katherine M Burke, Narghes Calcagno, et al.
Muscle & Nerve|November 6, 2025
Participation in U.S.-Based ALS Clinical Trials by Sex and RaceMark P Levine, Sun Young Chung, Kellen H Quigg, et al.
Muscle & Nerve|January 13, 2015
Electrical impedance myography in the evaluation of the tongue musculature in amyotrophic lateral sclerosisSanjana Shellikeri, Yana Yunusova, Jordan R Green, et al.
Drugs|September 19, 2022
Pharmacotherapy for Amyotrophic Lateral Sclerosis: A Review of Approved and Upcoming AgentsStephen A Johnson, Ton Fang, Fabiola De Marchi, et al.
Molecular Biology of the Cell|July 11, 2014
FUS is sequestered in nuclear aggregates in ALS patient fibroblastsJacob C Schwartz, Elaine R Podell, Steve S W Han, et al.
Plos One|May 6, 2016
Predicting Speech Intelligibility Decline in Amyotrophic Lateral Sclerosis Based on the Deterioration of Individual Speech SubsystemsPanying Rong, Yana Yunusova, Jun Wang, et al.
Toxicology Reports|December 26, 2015
Preclinical Rodent Toxicity Studies for Long Term Use of CeftriaxoneElena Ratti, James D Berry, David J Greenblatt, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 5, 2021
Development and validation of a machine-learning ALS survival model lacking vital capacity (VC-Free) for use in clinical trials during the COVID-19 pandemicDanielle Beaulieu, James D Berry, Sabrina Paganoni, et al.
Pageof 18

Showing results (31-40 of 176) with videos related to

Sort By:
Pageof 18
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 5, 2026
Bridging the gap: understanding participation barriers in ALS clinical trials through on-the-ground insightsErica Scirocco, Allison Pogemiller Bulat, Judith R Carey, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 19, 2012
Dexpramipexole effects on functional decline and survival in subjects with amyotrophic lateral sclerosis in a Phase II study: subgroup analysis of demographic and clinical characteristicsStacy A Rudnicki, James D Berry, Evan Ingersoll, et al.
Journal of Neuroengineering and Rehabilitation|December 20, 2024
Free-living monitoring of ALS progression in upper limbs using wearable accelerometersMarcin Straczkiewicz, Katherine M Burke, Narghes Calcagno, et al.
Muscle & Nerve|November 6, 2025
Participation in U.S.-Based ALS Clinical Trials by Sex and RaceMark P Levine, Sun Young Chung, Kellen H Quigg, et al.
Muscle & Nerve|January 13, 2015
Electrical impedance myography in the evaluation of the tongue musculature in amyotrophic lateral sclerosisSanjana Shellikeri, Yana Yunusova, Jordan R Green, et al.
Drugs|September 19, 2022
Pharmacotherapy for Amyotrophic Lateral Sclerosis: A Review of Approved and Upcoming AgentsStephen A Johnson, Ton Fang, Fabiola De Marchi, et al.
Molecular Biology of the Cell|July 11, 2014
FUS is sequestered in nuclear aggregates in ALS patient fibroblastsJacob C Schwartz, Elaine R Podell, Steve S W Han, et al.
Plos One|May 6, 2016
Predicting Speech Intelligibility Decline in Amyotrophic Lateral Sclerosis Based on the Deterioration of Individual Speech SubsystemsPanying Rong, Yana Yunusova, Jun Wang, et al.
Toxicology Reports|December 26, 2015
Preclinical Rodent Toxicity Studies for Long Term Use of CeftriaxoneElena Ratti, James D Berry, David J Greenblatt, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 5, 2021
Development and validation of a machine-learning ALS survival model lacking vital capacity (VC-Free) for use in clinical trials during the COVID-19 pandemicDanielle Beaulieu, James D Berry, Sabrina Paganoni, et al.
Pageof 18